Details

---

Manufacturer
KRKA, d.d., Novo mesto(SLOVENIA)
Registraction Number
MAL24116016AZ

Here’s a detailed overview of Glypvilo 50 mg tablets:

Content

Active Ingredient: Vildagliptin (50 mg).
Excipients: Includes lactose monohydrate, microcrystalline cellulose, and other inactive ingredients.

Indications

Type 2 Diabetes Mellitus: Glypvilo is used to improve blood sugar control in adults with type 2 diabetes. It is prescribed as:
Monotherapy when metformin is not suitable.
Combination therapy with other antidiabetic medications, including insulin, when these alone do not provide adequate control.

Instructions

Dosage:
Typically, 50 mg once or twice daily, depending on whether it is used alone or in combination with other medications.
Dosage adjustments may be required for patients with kidney impairment.
Administration:
Taken orally, with or without food.
Swallow the tablet whole with water.
Precautions:
Not recommended for patients with severe liver impairment
Regular monitoring of liver function is advised.
Avoid use during pregnancy or breastfeeding unless specifically directed by a doctor.